Gal-475 is under clinical development by Neurim Pharmaceuticals and currently in Phase I for Sleep Apnea. According to GlobalData, Phase I drugs for Sleep Apnea have a 96% phase t ...
People with high blood pressure who slept for shorter durations were more likely to show poor cognitive function and increased levels of markers of brain aging and injury, a new study has found.